Dose-comparative study of sitafloxacin in complicated urinary tract infections

Japanese Journal of Chemotherapy

Volumn 56, Issue SUPPL. 1, 2008, Pages 92-102

  Kawada, Yukimichi ^a   Yasuda, Mitsuru ^b   Tanaka, Kazushi ^c   Monden, Koichi ^d   Akasaka, Soichiro ^e   Egashira, Toshihisa ^f   Kaku, Mitsuo ^g   Hori, Seiji ^h  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d OKAYAMA UNIVERSITY   (Japan)

^e UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^f KYUSHU UNIVERSITY   (Japan)

^g TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^h JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Complicated urinary tract infection; Dose finding study; Double blind study; Sitafloxacin

Indexed keywords

ANTIINFECTIVE AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SITAFLOXACIN;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ABNORMAL SENSATION; ADULT; AGED; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BLURRED VISION; CHEILITIS; CLINICAL TRIAL; COMPARATIVE STUDY; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; CYSTITIS; DEFECATION DISORDER; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG STRUCTURE; DRUG TOLERABILITY; DYSGEUSIA; DYSPEPSIA; EOSINOPHIL COUNT; ERADICATION THERAPY; EYE DISEASE; FEMALE; FLATULENCE; GASTRITIS; GASTROINTESTINAL DISEASE; GLUCOSE BLOOD LEVEL; HARD FECES; HUMAN; HYPESTHESIA; INCIDENCE; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NAUSEA; NEUROLOGIC DISEASE; NEUTROPHIL COUNT; NONHUMAN; ORAL HYPESTHESIA; PATIENT COMPLIANCE; POTASSIUM BLOOD LEVEL; PROTEIN URINE LEVEL; PRURITUS; PYELONEPHRITIS; RANDOMIZED CONTROLLED TRIAL; RECOMMENDED DRUG DOSE; SIDE EFFECT; SKIN DISEASE; STOMACH DISCOMFORT; THIRST; UPPER ABDOMINAL PAIN; URINARY TRACT INFECTION;

EID: 43449084945     PISSN: 13407007     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Sato K, Hoshino K, Tanaka M, Hayakawa I, Osada Y: Antimicrobial activity of DU-6859, a new potent fluoroquinolone, against clinical isolates. Antimicrob Agents Chemother 1992; 36: 1491-8
2. Nakashima M, Uematsu T, Kosuge K, Umemura K, Hakusui H, Tanaka M: Pharmacokinetics and tolerance of DU-6859a, a new fluoroquinolone, after single and multiple oral doses in healthy volunteers. Antimicrob Agents Chemother 1995; 39:170-4
3. Hori S, Kobayashi H, Saito A, Kawada Y, Baba S, Sasaki J, et al: Clinical trials of sitafloxacin (DU-6859 a). Clinical Safety Profile. 47th Interscience Conference on Antimicrobial Agents and Chemotherapy 2007; L-489
4. Japanese source.
5. Japanese source.
6. Japanese source.
7. Japanese source.
8. Japanese source.
9. Japanese source.
10. Kawada Y, Kaku M, Yasuda M, Tanaka K, Monden K, Akasaka S, et al: Clinical trial of sitafloxacin (DU-6859a): Microbiologic and genetic characterization of isolates from complicated urinary tract infections. 47 th Interscience Conference on Antimicrobial Agents and Chemotherapy 2007; L495